Freeline Therapeutics Holdings plc — Net Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/7e356815-bdf6-4ec9-bee7-85a5c0523c7a/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-89.0M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-011688 |
| FY 2021 | $-140.4M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-012988 |
| FY 2020 | $-96.3M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-017066 |
| FY 2019 | $-53.9M | 2019-01-01 – 2019-12-31 | evidence 0001564590-21-017066 |
| FY 2018 | $-33.3M | 2018-01-01 – 2018-12-31 | evidence 0001564590-21-017066 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Freeline Therapeutics Holdings plc — all facts · Operating Income